1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €12.93 (+35.25%). The median is €12.93 (+35.25%).
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 237.41M | 7.37% |
| Gross profit | 142.2M | 8.38% |
| Net profit | -355.8M | 2,943.27% |
| EBITDA | -324.75M | 488.82% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.72B |
Number of shares | 169.9M |
52-week high/low | €11.45 - €3.98 |
| Dividends | No |
Beta | 1.72 |
P/E ratio | -27.19 |
PEG ratio | -0.41 |
P/B ratio | 1.92 |
P/S ratio | 1.69 |
Company profile
| Name | Trulieve Cannabis |
| CEO | Kimberly A. Rivers |
| Employees | 5,000 |
Discover assets
Shareholders of Trulieve Cannabis also invest in the following assets
